Atlas Trials

Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients

Clinical trial NCT02461758 · COMPLETED

Trial details

NCT number
NCT02461758
Sponsor
University of Wisconsin, Madison
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Inflammatory Bowel Disease (IBD)
Start date
2016-10-01
Primary completion
2018-06-01
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.